These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
207 related articles for article (PubMed ID: 31500862)
1. Chronology and Determinants of Respiratory Function Changes Following Administration of Systemic Postnatal Corticosteroids in Extremely Preterm Infants. Dassios T; Kaltsogianni O; Hickey A; Bhat R; Greenough A J Pediatr; 2019 Dec; 215():17-23. PubMed ID: 31500862 [TBL] [Abstract][Full Text] [Related]
2. Oxygen saturation/FIO2 ratio at 36 weeks' PMA in 1005 preterm infants: Effect of gestational age and early respiratory disease patterns. Nobile S; Marchionni P; Gidiucci C; Correani A; Palazzi ML; Spagnoli C; Rondina C; ; Carnielli VP Pediatr Pulmonol; 2019 May; 54(5):637-643. PubMed ID: 30688034 [TBL] [Abstract][Full Text] [Related]
3. Second course of systemic dexamethasone: efficacy and respiratory function changes. Dassios T; Kaltsogianni O; Greenough A J Matern Fetal Neonatal Med; 2022 Apr; 35(7):1401-1404. PubMed ID: 32290737 [TBL] [Abstract][Full Text] [Related]
4. Using Measurements of Shunt and Ventilation-to-Perfusion Ratio to Quantify the Severity of Bronchopulmonary Dysplasia. Dassios T; Curley A; Morley C; Ross-Russell R Neonatology; 2015; 107(4):283-8. PubMed ID: 25766074 [TBL] [Abstract][Full Text] [Related]
5. Inhalation or instillation of steroids for the prevention of bronchopulmonary dysplasia. Bassler D Neonatology; 2015; 107(4):358-9. PubMed ID: 26044104 [TBL] [Abstract][Full Text] [Related]
6. Randomized Trial of 42-Day Compared with 9-Day Courses of Dexamethasone for the Treatment of Evolving Bronchopulmonary Dysplasia in Extremely Preterm Infants. Marr BL; Mettelman BB; Bode MM; Gross SJ J Pediatr; 2019 Aug; 211():20-26.e1. PubMed ID: 31349916 [TBL] [Abstract][Full Text] [Related]
7. Inhaled versus systemic corticosteroids for the treatment of chronic lung disease in ventilated very low birth weight preterm infants. Shah SS; Ohlsson A; Halliday H; Shah VS Cochrane Database Syst Rev; 2003; (2):CD002057. PubMed ID: 12804423 [TBL] [Abstract][Full Text] [Related]
8. Inhaled versus systemic corticosteroids for the treatment of chronic lung disease in ventilated very low birth weight preterm infants. Shah SS; Ohlsson A; Halliday H; Shah VS Cochrane Database Syst Rev; 2007 Oct; (4):CD002057. PubMed ID: 17943765 [TBL] [Abstract][Full Text] [Related]
9. Postnatal Steroids Use for Bronchopulmonary Dysplasia in a Quaternary Care NICU. Kanagaraj U; Tan J; Soraisham A; Lodha A; Shah P; Kulkarni T; Shivananda S Am J Perinatol; 2024 Oct; 41(13):1858-1866. PubMed ID: 38350641 [TBL] [Abstract][Full Text] [Related]
10. Inhaled versus systemic corticosteroids for the treatment of chronic lung disease in ventilated very low birth weight preterm infants. Shah SS; Ohlsson A; Halliday HL; Shah VS Cochrane Database Syst Rev; 2012 May; (5):CD002057. PubMed ID: 22592682 [TBL] [Abstract][Full Text] [Related]
11. Dexamethasone, Prednisolone, and Methylprednisolone Use and 2-Year Neurodevelopmental Outcomes in Extremely Preterm Infants. Puia-Dumitrescu M; Wood TR; Comstock BA; Law JB; German K; Perez KM; Gogcu S; Mayock DE; Heagerty PJ; Juul SE; JAMA Netw Open; 2022 Mar; 5(3):e221947. PubMed ID: 35275165 [TBL] [Abstract][Full Text] [Related]
12. Volume targeting levels and work of breathing in infants with evolving or established bronchopulmonary dysplasia. Hunt K; Dassios T; Ali K; Greenough A Arch Dis Child Fetal Neonatal Ed; 2019 Jan; 104(1):F46-F49. PubMed ID: 29305407 [TBL] [Abstract][Full Text] [Related]
13. The effect of postnatal corticosteroids on growth parameters in infants with bronchopulmonary dysplasia. Williams EE; Dassios T; Mann M; Greenough A J Perinat Med; 2021 Nov; 49(9):1141-1144. PubMed ID: 34087969 [TBL] [Abstract][Full Text] [Related]
14. A multicenter, randomized open study of early corticosteroid treatment (OSECT) in preterm infants with respiratory illness: comparison of early and late treatment and of dexamethasone and inhaled budesonide. Halliday HL; Patterson CC; Halahakoon CW; Pediatrics; 2001 Feb; 107(2):232-40. PubMed ID: 11158452 [TBL] [Abstract][Full Text] [Related]
15. Timing of postnatal corticosteroid treatment for bronchopulmonary dysplasia and its effect on outcomes. Cuna A; Lewis T; Dai H; Nyp M; Truog WE Pediatr Pulmonol; 2019 Feb; 54(2):165-170. PubMed ID: 30537393 [TBL] [Abstract][Full Text] [Related]
16. Effect of intubation and mechanical ventilation on exhaled nitric oxide in preterm infants with and without bronchopulmonary dysplasia measured at a median postmenstrual age of 49 weeks. Schmalisch G; Wilitzki S; Fischer HS; Bührer C BMC Res Notes; 2014 Jun; 7():389. PubMed ID: 24957096 [TBL] [Abstract][Full Text] [Related]
17. Late Surfactant Administration in Very Preterm Neonates With Prolonged Respiratory Distress and Pulmonary Outcome at 1 Year of Age: A Randomized Clinical Trial. Hascoët JM; Picaud JC; Ligi I; Blanc T; Moreau F; Pinturier MF; Zupan V; Guilhoto I; Hamon IR; Alexandre C; Bouissou A; Storme L; Patkai J; Pomedio M; Rouabah M; Coletto L; Vieux R JAMA Pediatr; 2016 Apr; 170(4):365-72. PubMed ID: 26928567 [TBL] [Abstract][Full Text] [Related]
18. Inhaled corticosteroids in ventilated preterm neonates: a non-randomized dose-ranging study. Raghuram K; Dunn M; Jangaard K; Reilly M; Asztalos E; Kelly E; Vincer M; Shah V BMC Pediatr; 2018 May; 18(1):153. PubMed ID: 29734948 [TBL] [Abstract][Full Text] [Related]
19. Respiratory Support for Very Low Birth Weight Infants Receiving Dexamethasone. Virkud YV; Hornik CP; Benjamin DK; Laughon MM; Clark RH; Greenberg RG; Smith PB J Pediatr; 2017 Apr; 183():26-30.e3. PubMed ID: 28108103 [TBL] [Abstract][Full Text] [Related]